As more emerging biopharma companies, novel active substances, biosimilars and generics enter the market and higher investment is made in R&D for new drugs, tech can transform patient support programs to ensure market differentiation.
In this Drug Channels article, Chief Commercial Officer Edward Hensley offers his insights on the five ways technology life sciences companies can use technology to transform their patient support services and thus differentiate their products.
Drug Channels is one of the industry’s leading publications offering expert insights on pharmaceutical economics and the drug distribution systems.